Hypofractionated radiation treatment

RADIATION2 trials

Sponsors

AHS Cancer Control Alberta, M.D. Anderson Cancer Center

Conditions

Bone MetastasesHigh-risk Prostate Cancer

Phase 2

A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms

CompletedNCT02163226

M.D. Anderson Cancer CenterBone Metastases

Start: 2014-08-06End: 2020-09-02Updated: 2021-11-08

Unknown Phase

Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients

TerminatedNCT01488968

AHS Cancer Control AlbertaHigh-risk Prostate Cancer

Start: 2012-03-31End: 2018-10-15Updated: 2025-06-29

Related Papers

Single-fraction stereotactic versus standard conventional multifraction radiation for predominantly non-spine bone metastases: A randomized phase II trial.

Journal of Clinical Oncology2019-05-20

Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases

JAMA Oncology2019-04-25219 citations